Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
HDA Statement on FDA Commissioner Nominee Dr. Robert Califf
Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement regarding President Biden’s nomination of Dr. Robert Califf as FDA Commissioner.
HDA Responds to the FTC/HHS Request for Information on Drug Shortages
The Healthcare Distribution Alliance (HDA) submitted comments to the Department of Health and Human Services (HHS) and the Federal Trade Commission (FTC) in response to the agencies’ joint Request for Information (RFI) on “Solicitation for Public Comment to Understand Lack of Competition and Contracting Practices that May be Contributing to Drug Shortages.”
How 2023 Will Shape the Future of Healthcare Supply Chain Resilience
Recently, HDA surveyed our distributor members and other subject matter experts to gain insights into current data and information sharing within the healthcare sector, and these findings have been distilled in our latest report, Healthcare Supply Chain Resilience and Data Illumination. This report documents the role of public-private partnerships in the COVID-19 response, while outlining some challenges and actionable recommendations to maintain long-standing data-sharing agreements. Read to learn more about these topics and the report's findings.
HDA Statement on Maryland Legislation Designed to Clarify Role of Critical Pharmacy Partners
The Healthcare Distribution Alliance (HDA) issued the following statement today from HDA Senior Vice President of State Government Affairs and Alliance Development Matt DiLoreto, upon introduction of SB 823 and HB 973 by the Maryland Legislature.
Healthcare Distributors Are Making a Difference in Local Communities
Long before the COVID-19 pandemic, HDA healthcare distributors recognized the vital role that philanthropy plays in building healthier communities — and the industry’s responsibility in leading these efforts.